152 related articles for article (PubMed ID: 18415657)
1. ESHAP therapy effective in a patient with Langerhans cell sarcoma.
Yoshimi A; Kumano K; Motokura T; Takazawa Y; Oota S; Chiba S; Takahashi T; Fukayama M; Kurokawa M
Int J Hematol; 2008 Jun; 87(5):532-537. PubMed ID: 18415657
[TBL] [Abstract][Full Text] [Related]
2. Langerhans cell sarcoma of the nasopharynx: a rare case.
Keklik M; Sivgin S; Kontas O; Abdulrezzak U; Kaynar L; Cetin M
Scott Med J; 2013 Nov; 58(4):e17-20. PubMed ID: 24215052
[TBL] [Abstract][Full Text] [Related]
3. Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma.
Intragumtornchai T; Bunworasate U; Nakorn TN; Rojnuckarin P
Leuk Lymphoma; 2006 Jul; 47(7):1306-14. PubMed ID: 16923561
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy.
Matsukawa T; Suto K; Miyoshi H; Oshimi K; Ohshima K; Miyagishima T
J Clin Exp Hematop; 2018 Dec; 58(4):184-187. PubMed ID: 30305476
[No Abstract] [Full Text] [Related]
5. Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide.
Yamaguchi M; Kotani T; Nakamura Y; Ueda M
Int J Hematol; 2006 Jun; 83(5):450-3. PubMed ID: 16787878
[TBL] [Abstract][Full Text] [Related]
6. Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma.
Mercadal S; Briones J; Xicoy B; Pedro C; Escoda L; Estany C; Camós M; Colomo L; Espinosa I; Martínez S; Ribera JM; Martino R; Gutiérrez-García G; Montserrat E; López-Guillermo A;
Ann Oncol; 2008 May; 19(5):958-63. PubMed ID: 18303032
[TBL] [Abstract][Full Text] [Related]
7. CHOP versus CHOP plus ESHAP and high-dose therapy with autologous peripheral blood progenitor cell transplantation for high-intermediate-risk and high-risk aggressive non-Hodgkin's lymphoma.
Intragumtornchai T; Prayoonwiwat W; Numbenjapon T; Assawametha N; O'Charoen R; Swasdikul D
Clin Lymphoma; 2000 Dec; 1(3):219-25. PubMed ID: 11707834
[TBL] [Abstract][Full Text] [Related]
8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
9. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
10. Value of frontline autologous stem-cell transplantation in peripheral T-cell lymphoma.
Gutierrez A; Rodriguez J
Ann Oncol; 2008 Aug; 19(8):1512. PubMed ID: 18662957
[No Abstract] [Full Text] [Related]
11. Hepatosplenic alphabeta T cell lymphoma.
Nagai Y; Ikegame K; Mori M; Inoue D; Kimura T; Shimoji S; Togami K; Tabata S; Kurata M; Imai Y; Matsushita A; Nagai K; Ogawa H; Takahashi T
Int J Clin Oncol; 2010 Apr; 15(2):215-9. PubMed ID: 20217452
[TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
Martelli M; Vignetti M; Zinzani PL; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli MF; Calabresi F; Tura S; Mandelli F
J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
[TBL] [Abstract][Full Text] [Related]
13. High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma.
Bi J; Espina BM; Tulpule A; Boswell W; Levine AM
J Acquir Immune Defic Syndr; 2001 Dec; 28(5):416-21. PubMed ID: 11744828
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.
Wilder RB; Rodriguez MA; Tucker SL; Ha CS; Hess MA; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):743-9. PubMed ID: 11395243
[TBL] [Abstract][Full Text] [Related]
15. [Autologous hematopoietic stem cell transplantation followed by oral bexarotene in a patient with advanced mycosis fungoides].
Pérez-Barrio S; Izu R; García-Ruiz JC; Acebo E; Martínez de Lagrán Z; Díaz-Pérez JL
Actas Dermosifiliogr; 2008 Sep; 99(7):560-4. PubMed ID: 18682170
[TBL] [Abstract][Full Text] [Related]
16. A case of CD20-positive peripheral T-cell lymphoma treated with rituximab and multiagent chemotherapy.
Kamata M; Sugaya M; Miyagaki T; Sonoda K; Ichimura Y; Mitsui H; Sato S; Kamikubo Y; Kurokawa M
Int J Dermatol; 2014 Jan; 53(1):e24-6. PubMed ID: 23452101
[No Abstract] [Full Text] [Related]
17. Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Tsimberidou AM; McLaughlin P; Younes A; Rodriguez MA; Hagemeister FB; Sarris A; Romaguera J; Hess M; Smith TL; Yang Y; Ayala A; Preti A; Lee MS; Cabanillas F
Blood; 2002 Dec; 100(13):4351-7. PubMed ID: 12393618
[TBL] [Abstract][Full Text] [Related]
18. [Durable remission of Langerhans cell sarcoma attained by autologous hematopoietic stem cell transplantation following surgical resection].
Fuseya H; Nakao T; Tsutsumi M; Nakaya Y; Horiuchi M; Yoshida M; Yoshimura T; Hayashi Y; Fukushima H; Inoue T; Aiba T; Yamane T
Rinsho Ketsueki; 2019; 60(4):314-318. PubMed ID: 31068562
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphomas: a review of the M.D. Anderson experience.
Cabanillas F
Semin Oncol; 1992 Feb; 19(1 Suppl 1):11-3. PubMed ID: 1384134
[TBL] [Abstract][Full Text] [Related]
20. Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.
Martín A; Redondo AM; Dlouhy I; Salar A; González-Barca E; Canales M; Montes-Moreno S; Ocio EM; López-Guillermo A; Caballero D;
Br J Haematol; 2016 Apr; 173(2):245-52. PubMed ID: 26847165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]